Novo Nordisk stock news
Novo Nordisk has entered into a strategic partnership with OpenAI to integrate advanced artificial intelligence across its global operations, including drug discovery, clinical trials, and manufacturing. This collaboration is designed to accelerate research and development cycles and optimize the company's ability to identify and develop new therapies for chronic diseases.